US SB4037 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on April 7 2022 - 25% progression, died in committee
Action: 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 7 2022 - 25% progression, died in committee
Action: 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes.
Title
Pharmaceutical Research Transparency Act of 2022
Sponsors
Sen. Debbie Stabenow [D-MI] | Sen. Tina Smith [D-MN] | Sen. Amy Klobuchar [D-MN] |
History
Date | Chamber | Action |
---|---|---|
2022-04-07 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB4747 (Same As) 2021-08-04 - Referred to the Subcommittee on Asia, the Pacific, Central Asia and Nonproliferation.
HB7474 (Same As) 2022-04-08 - Referred to the Subcommittee on Health.
HB7474 (Same As) 2022-04-08 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/senate-bill/4037/all-info |
Text | https://www.congress.gov/117/bills/s4037/BILLS-117s4037is.pdf |